CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
High-Purity Type I Collagen (HPTC) Nerve Wrapdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07360730
NCT07360730N/ACompleted

Prospective Multicentre Registry of High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: Early Clinical Outcomes

Adichunchanagiri Institute of Medical Sciences, B G Nagara·interventional·Posted Jan 22, 2026·Updated Mar 30, 2026

In Brief

A clinical study evaluating High-Purity Type I Collagen (HPTC) Nerve Wrap for Peripheral Nerve Injuries and 4 related conditions. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

This prospective multicentre observational registry evaluates early clinical outcomes following the use of High-Purity Type I Collagen (HPTC) as a circumferential nerve wrap during peripheral nerve procedures. Eligible procedures include nerve repair, coaptation, grafting, nerve transfers, and decompressions in the upper and lower limbs. Primary outcomes include early motor recovery assessed using the Medical Research Council (MRC) motor grading system. Secondary outcomes include sensory recovery, neuropathic pain, patient-reported functional outcomes, complication rates, and patient satisfaction assessed at standardized postoperative intervals up to two months.

Study Details

Timeline

N/ACompletedFinished
2026
First PostedJan 22, 2026
Enrollment StartDec 9, 2025
Primary CompletionFeb 26, 2026
Study CompletionMar 3, 2026
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5 months ago

Interventions

High-Purity Type I Collagen (HPTC) Nerve Wrapdevice

After completion of nerve repair, coaptation, grafting, transfer, or decompression, a sterile HPTC collagen membrane is hydrated as per manufacturer instructions, trimmed to the length of the treated nerve segment (approximately 1.5-4 cm), and wrapped circumferentially as a loose perineural sleeve. The wrap is secured using fibrin glue or fine absorbable sutures. Standard wound closure and postoperative rehabilitation protocols are followed.